Arca Biopharma | ABIO - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
Amgen 19.84 5.47 2026-03
Biogen 13.7 0.32 2026-03
Brainstorm Cell Therapeutics 0.03 5.89 2025-09
Bristol-Myers Squibb 9.08 0.2 2026-03
Capricor Therapeutics 2.76K 2.76K 2022-12
Cipla 23.56 4.18 2026-03
Clal Biotechnology 11.67 2.62 2022-12
Compugen 4.06 75.75 2025-12
CSL 16.16 9.59 2025-12
Daiichi Sankyo 20.73 1.74 2025-12
Gilead Sciences 17.7 2.07 2026-03
GlaxoSmithKline 14.87 3.72 2026-03
Grifols 11.2 1.08 2025-12
Laboratory Of America 25.51 4.65 2026-03
Otsuka Holdings 14.31 2.24 2026-03
Pfizer 9.32 5.16 2026-03
United Therapeutics 20.42 3.1 2026-03